We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RRC:NYSERange Resources Corporation Analysis

Data as of 2026-06-17 - not real-time

$37.51

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Range Resources trades at $37.51, well below its DCF‑derived fair value of $80.88, implying roughly a 115% intrinsic upside and a 26% upside relative to the current price. Valuation multiples are attractive – a trailing P/E of 9.9 versus the industry average of 20.7 and a price‑to‑book of 1.92, while the dividend yield of 1.07% is supported by a very low payout ratio of under 10% and robust free cash flow. Fundamentally, the company delivered 26% revenue growth, 44% operating margin, and a strong ROE of 21%.
Technically, the stock is sitting just above its near‑term support at $36.80, with the 20‑day SMA (39.6) and 50‑day SMA (41.1) both above price, a bearish MACD histogram, and an RSI of 35.6 indicating mild oversold conditions. Volatility is elevated at 28.7% over the past 30 days, but beta is modest (0.404), suggesting limited market‑wide swings. The recent declaration of a quarterly cash dividend of $0.10 per share adds a modest income cushion, but the short‑term price action remains constrained by bearish technical signals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near the $36.80 support level
  • Bearish MACD histogram and SMA crossover
  • RSI indicating mild oversold condition

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value suggests >100% intrinsic upside
  • Strong revenue growth (26%) and high operating margins
  • Low dividend payout ratio preserving cash for growth

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend backed by solid free cash flow
  • Undervalued multiples relative to industry peers
  • Long‑term natural gas position in the Appalachian basin

Key Metrics & Analysis

Financial Health

Revenue Growth26.10%
Profit Margin28.12%
P/E Ratio9.9
ROE21.13%
ROA10.91%
Debt/Equity21.27
P/B Ratio1.9
Op. Cash Flow$1.5B
Free Cash Flow$554.7M
Industry P/E20.7

Technical Analysis

TrendNeutral
RSI35.6
Support$36.80
Resistance$43.31
MA 20$39.61
MA 50$41.14
MA 200$38.65
MACDBearish
VolumeStable
Fear & Greed Index92.13

Valuation

Fair Value$80.88
Target Price$47.32
Upside/Downside26.15%
GradeUndervalued
TypeBlend
Dividend Yield1.07%

Risk Assessment

Beta-0.02
Volatility28.69%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.